Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-014676
Filing Date
2021-03-23
Accepted
2021-03-23 06:30:49
Documents
83
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K idya-10k_20201231.htm 10-K 3493718
2 EX-4.3 idya-ex43_1080.htm EX-4.3 34371
3 EX-10.9 idya-ex109_1522.htm EX-10.9 139311
4 EX-23.1 idya-ex231_12.htm EX-23.1 1728
5 EX-31.1 idya-ex311_9.htm EX-31.1 18407
6 EX-31.2 idya-ex312_11.htm EX-31.2 18460
7 EX-32.1 idya-ex321_10.htm EX-32.1 12391
8 GRAPHIC g342xvvma22s000001.jpg GRAPHIC 113077
9 GRAPHIC g342xvvma22s000002.jpg GRAPHIC 30760
  Complete submission text file 0001564590-21-014676.txt   10296113

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT idya-20201231.xml EX-101.INS 1779534
11 XBRL TAXONOMY EXTENSION SCHEMA idya-20201231.xsd EX-101.SCH 68564
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idya-20201231_cal.xml EX-101.CAL 65766
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idya-20201231_def.xml EX-101.DEF 267009
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE idya-20201231_lab.xml EX-101.LAB 556629
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idya-20201231_pre.xml EX-101.PRE 435320
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38915 | Film No.: 21763114
SIC: 2834 Pharmaceutical Preparations